Core inhibitor therapy for chronic hepatitis B

Lancet Gastroenterol Hepatol. 2020 Feb;5(2):99-100. doi: 10.1016/S2468-1253(19)30325-5. Epub 2019 Nov 9.
No abstract available

Publication types

  • Review

MeSH terms

  • Antiviral Agents / therapeutic use
  • DNA, Viral / analysis*
  • Global Health
  • Hepatitis B virus / genetics*
  • Hepatitis B, Chronic / drug therapy*
  • Hepatitis B, Chronic / epidemiology
  • Hepatitis B, Chronic / virology
  • Humans
  • Incidence
  • Interferon-alpha / therapeutic use*
  • Polyethylene Glycols / therapeutic use*
  • Recombinant Proteins / therapeutic use

Substances

  • Antiviral Agents
  • DNA, Viral
  • Interferon-alpha
  • Recombinant Proteins
  • Polyethylene Glycols
  • peginterferon alfa-2a